,for, Item ID-
  • #1257867
  • Sumitomo Pharma America #72974041501

MYFEMBREE® Relugolix / Estradiol / Norethindrone 40 mg / 1 mg / 0.5 mg Tablet 28 Tablets

MYFEMBREE, TAB 40MG/1MG/0.5MG (28/BT)

No Image

Features

  • MYFEMBREE is a combination of relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, estradiol, an estrogen, and norethindrone acetate, a progestin, indicated in premenopausal women for the: management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids), and management of moderate to severe pain associated with endometriosis
  • Film-coated tablets
  • More …
  Log In to Order
or

Product Specifications


Features
  • MYFEMBREE is a combination of relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, estradiol, an estrogen, and norethindrone acetate, a progestin, indicated in premenopausal women for the: management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids), and management of moderate to severe pain associated with endometriosis
  • Film-coated tablets

Frequently Viewed Together